Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Indaba Capital Management, L.P.

Q3 2024 · 13F-HR

Indaba Capital Management, L.P.holdings as filed

Filed 2024-11-14 · accession 0001011438-24-000663

$233.7M
Reported value
9
Positions
2024-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
294628102HP5AEQUITY COMWLTH$93.5M40.0%4,700,000CommonSOLE
29664WAB1ESPR 4 11/15/25ESPERION THERAPEUTICS INC NE$32.0M13.7%33,750,000CommonSOLE
05988JAD5BAND 0.5 04/01/28BANDWIDTH INC$31.4M13.4%40,250,000CommonSOLE
68339B104ONTFON24 INC$26.0M11.1%4,240,256CommonSOLE
98423FAB5XMTR 1 02/01/27XOMETRY INC$18.6M7.94%21,750,000CommonSOLE
00430HAC6ACCELERATE DIAGNOSTICS INC$12.4M5.31%24,083,901CommonSOLE
46333XAH1IRWD 1.5 06/15/26IRONWOOD PHARMACEUTICALS INC$8.0M3.41%9,000,000CommonSOLE
34385PAF5STANDARD BIOTOOLS INC$7.6M3.27%7,660,000CommonSOLE
866082AA8INN 1.5 02/15/26SUMMIT HOTEL PPTYS$4.2M1.82%4,500,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.